An eleven gene molecular signature for extra-capsular spread in oral squamous cell carcinoma serves as a prognosticator of outcome in patients without nodal metastases

Oral Oncology

Volumn 51, Issue 4, 2015, Pages 355-362

  Wang, Weining ^a   Lim, Weng Khong ^b   Leong, Hui Sun ^a   Chong, Fui Teen ^a   Lim, Tony K H ^c   Tan, Daniel S W ^a,b   Teh, Bin Tean ^a   Iyer, N Gopalakrishna ^a,b  

^a DIVISION OF MEDICAL ONCOLOGY   (Singapore)

^b DUKE NUS MEDICAL SCHOOL   (Singapore)

^c SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

Extracapsular spread; Gene molecular signature; Oral squamous cell carcinoma; Prognostic factor

Indexed keywords

ARTICLE; CANCER GENETICS; CANCER PROGNOSIS; CANCER SURVIVAL; CONTROLLED STUDY; GENE EXPRESSION PROFILING; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; METASTASIS; MOUTH SQUAMOUS CELL CARCINOMA; PRIORITY JOURNAL; RNA SEQUENCE; SEQUENCE ANALYSIS; FEMALE; GENETICS; LYMPH NODE METASTASIS; MALE; MOUTH TUMOR; PATHOLOGY; PROGNOSIS; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; FEMALE; GENE EXPRESSION PROFILING; HUMANS; LYMPHATIC METASTASIS; MALE; MOUTH NEOPLASMS; NEOPLASM METASTASIS; PROGNOSIS;

EID: 84933679420     PISSN: 13688375     EISSN: 18790593     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2014.12.012     Document Type: Article

References (56)

1. Institute NC. SEER cancer statistics review 1975-2010;2013.
2. Krishna Rao SV, Mejia G Fau-Roberts-Thomson K, Roberts-Thomson K Fau-Logan R, Logan R. Epidemiology of oral cancer in Asia in the past decade-an update (2000-2012).
3. Huang SH, O'Sullivan B. Oral cancer: current role of radiotherapy and chemotherapy. Medicina oral, patologia oraly cirugia bucal 2013;18:e233-40.
4. Studer G, Zwahlen RA, Graetz KW, Davis BJ, Glanzmann C. IMRT in oral cavity cancer. Radiat Oncol (London, England) 2007;2:16.
5. Franceschi D, Gupta R, Spiro RH, Shah JP. Improved survival in the treatment of squamous carcinoma of the oral tongue. Am J Surg 1993;166:360-5.
6. Rikardsen OG, Bjerkli IH, Uhlin-Hansen L, Hadler-Olsen E, Steigen SE. Clinicopathological characteristics of oral squamous cell carcinoma in Northern Norway: a retrospective study. BMC Oral Health 2014;14:103.
7. Jerjes W, Upile T, Petrie A, Riskalla A, Hamdoon Z, Vourvachis M, et al. Clinicopathological parameters, recurrence, locoregional and distant metastasis in 115 T1-T2 oral squamous cell carcinoma patients. Head & Neck Oncol 2010;2:9.
8. Larsen SR, Johansen J, Sorensen JA, Krogdahl A. The prognostic significance of histological features in oral squamous cell carcinoma. J Oral Pathol Med 2009;38:657-62.
9. Binmadi NO, Basile JR. Perineural invasion in oral squamous cell carcinoma: a discussion of significance and review of the literature. Oral Oncol 2011;47:1005-10.
10. Cooper JS, Pajak TF, Forastiere AA, Jacobs J, Campbell BH, Saxman SB, et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. New Engl J Med 2004;350:1937-44.
11. Bernier J, Domenge C, Ozsahin M, Matuszewska K, Lefebvre JL, Greiner RH, et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. New Engl J Med 2004;350:1945-52.
12. Puri SK, Fan CY, Hanna E. Significance of extracapsular lymph node metastases in patients with head and neck squamous cell carcinoma. Curr Opin Otolaryngol Head Neck Surg 2003;11:119-23.
13. Ghadjar P, Schreiber-Facklam H, Grater R, Evers C, Simcock M, Geretschlager A, et al. Quantitative analysis of extracapsular extension of metastatic lymph nodes and its significance in radiotherapy planning in head and neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 2010;76:1127-32.
14. Ferlito A, Rinaldo A, Devaney KO, MacLennan K, Myers JN, Petruzzelli GJ, et al. Prognostic significance of microscopic and macroscopic extracapsular spread from metastatic tumor in the cervical lymph nodes. Oral Oncol 2002;38:747-51.
15. Wilson CL, Miller CJ. Simpleaffy: a BioConductor package for Affymetrix Quality Control and data analysis. Bioinformatics (Oxford, England) 2005;21:3683-5.
16. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics (Oxford, England) 2003;4:249-64.
17. Dai M, Wang P, Boyd AD, Kostov G, Athey B, Jones EG, et al. Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data. Nucleic Acids Res 2005;33:e175.
18. Smyth GK. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 2004;3 [Article3].
19. Rickman DS, Millon R, De Reynies A, Thomas E, Wasylyk C, Muller D, et al. Prediction of future metastasis and molecular characterization of head and neck squamous-cell carcinoma based on transcriptome and genome analysis by microarrays. Oncogene 2008;27:6607-22.
20. van Hooff SR, Leusink FK, Roepman P, Baatenburg de Jong RJ, Speel EJ, van den Brekel MW, et al. Validation of a gene expression signature for assessment of lymph node metastasis in oral squamous cell carcinoma. J Clin Oncol: Off J Am Soc Clin Oncol 2012;30:4104-10.
21. Roepman P, Wessels LF, Kettelarij N, Kemmeren P, Miles AJ, Lijnzaad P, et al. An expression profile for diagnosis of lymph node metastases from primary head and neck squamous cell carcinomas. Nat Genet 2005;37:182-6.
22. Onken MD, Winkler AE, Kanchi KL, Chalivendra V, Law JH, Rickert CG, et al. A surprising cross-species conservation in the genomic landscape of mouse and human oral cancer identifies a transcriptional signature predicting metastatic disease. Clin Cancer Res: Off J Am Assoc Cancer Res 2014;20:2873-84.
23. Okuyemi OT, Piccirillo JF, Spitznagel E. TNM staging compared with a new clinicopathological model in predicting oral tongue squamous cell carcinoma survival. Head Neck 2013.
24. Thiagarajan S, Nair S, Nair D, Chaturvedi P, Kane SV, Agarwal JP, et al. Predictors of prognosis for squamous cell carcinoma of oral tongue. J Surg Oncol 2014;109:639-44.
25. Ebrahimi A, Gil Z, Amit M, Yen TC, Liao CT, Chaturvedi P, et al. The prognosis of N2b and N2c lymph node disease in oral squamous cell carcinoma is determined by the number of metastatic lymph nodes rather than laterality: evidence to support a revision of the American Joint Committee on Cancer staging system. Cancer 2014;120:1968-74.
26. Iyer NG, Kim L, Nixon IJ, Palmer F, Shah JP, Patel SG, et al. Outcome of patients with early T1 and T2 squamous cell carcinoma of the base of tongue managed by conventional surgery with adjuvant postoperative radiation. Head Neck 2013;35:999-1006.
27. Peng CH, Liao CT, Peng SC, Chen YJ, Cheng AJ, Juang JL, et al. A novel molecular signature identified by systems genetics approach predicts prognosis in oral squamous cell carcinoma. PLoS ONE 2011;6:e23452.
28. Peridis S, Pilgrim G, Athanasopoulos I, Parpounas K. Carbonic anhydrase-9 expression in head and neck cancer: a meta-analysis. Eur Arch Otorhinolaryngol 2011;268:661-70.
29. Shubbar E, Helou K, Kovacs A, Nemes S, Hajizadeh S, Enerback C, et al. High levels of gamma-glutamyl hydrolase (GGH) are associated with poor prognosis and unfavorable clinical outcomes in invasive breast cancer. BMC Cancer 2013;13:47.
30. Xing C, Xie H, Zhou L, Zhou W, Zhang W, Ding S, et al. Cyclin-dependent kinase inhibitor 3 is overexpressed in hepatocellular carcinoma and promotes tumor cell proliferation. Biochem Biophys Res Commun 2012;420:29-35.
31. Lee SW, Reimer CL, Fang L, Iruela-Arispe ML, Aaronson SA. Overexpression of kinase-associated phosphatase (KAP) in breast and prostate cancer and inhibition of the transformed phenotype by antisense KAP expression. Mol Cell Biol 2000;20:1723-32.
32. Lai MW, Chen TC, Pang ST, Yeh CT. Overexpression of cyclin-dependent kinaseassociated protein phosphatase enhances cell proliferation in renal cancer cells. Urol Oncol 2012;30:871-8.
33. Espinosa AM, Alfaro A, Roman-Basaure E, Guardado-Estrada M, Palma I, Serralde C, et al. Mitosis is a source of potential markers for screening and survival and therapeutic targets in cervical cancer. PLoS ONE 2013;8:e55975.
34. Hinz S, Kempkensteffen C, Christoph F, Krause H, Schrader M, Schostak M, et al. Expression parameters of the polycomb group proteins BMI1, SUZ12, RING1 and CBX7 in urothelial carcinoma of the bladder and their prognostic relevance. Tumour Biol: J Int Soc Oncodev Biol Med 2008;29:323-9.
35. Pallante P, Federico A, Berlingieri MT, Bianco M, Ferraro A, Forzati F, et al. Loss of the CBX7 gene expression correlates with a highly malignant phenotype in thyroid cancer. Cancer Res 2008;68:6770-8.
36. Pallante P, Terracciano L, Carafa V, Schneider S, Zlobec I, Lugli A, et al. The loss of the CBX7 gene expression represents an adverse prognostic marker for survival of colon carcinoma patients. Eur J Cancer (Oxford, England: 1990) 2010;46:2304-13.
37. Forzati F, Federico A, Pallante P, Abbate A, Esposito F, Malapelle U, et al. CBX7 is a tumor suppressor in mice and humans. J Clin Investig 2012;122:612-23.
38. Karamitopoulou E, Pallante P, Zlobec I, Tornillo L, Carafa V, Schaffner T, et al. Loss of the CBX7 protein expression correlates with a more aggressive phenotype in pancreatic cancer. Eur J Cancer (Oxford, England: 1990) 2010;46:1438-44.
39. Galivan J, Ryan TJ, Chave K, Rhee M, Yao R, Yin D. Glutamyl hydrolase. pharmacological role and enzymatic characterization. Pharmacol Ther 2000;85:207-15.
40. Nalepa G, Barnholtz-Sloan J, Enzor R, Dey D, He Y, Gehlhausen JR, et al. The tumor suppressor CDKN3 controls mitosis. J Cell Biol 2013;201:997-1012.
41. Gyuris J, Golemis E, Chertkov H, Brent R. Cdi1, a human G1 and S phase protein phosphatase that associates with Cdk2. Cell 1993;75:791-803.
42. Okamoto K, Kitabayashi I, Taya Y. KAP1 dictates p53 response induced by chemotherapeutic agents via Mdm2 interaction. Biochem Biophys Res Commun 2006;351:216-22.
43. Hsieh WJ, Hsieh SC, Chen CC, Wang FF. Human DDA3 is an oncoprotein downregulated by p53 and DNA damage. Biochem Biophys Res Commun 2008;369:567-72.
44. Sun WT, Hsieh PC, Chiang ML, Wang MC, Wang FF. P53 target DDA3 binds ASPP2 and inhibits its stimulation on p53-mediated BAX activation. Biochem Biophys Res Commun 2008;376:395-8.
45. Jang CY, Fang G. DDA3 associates with MCAK and controls chromosome congression. Biochem Biophys Res Commun 2011;407:610-4.
46. Jang CY, Coppinger JA, Yates 3rd JR, Fang G. Phospho-regulation of DDA3 function in mitosis. Biochem Biophys Res Commun 2010;393:259-63.
47. Zhang L, Shao H, Zhu T, Xia P, Wang Z, Liu L, et al. DDA3 associates with microtubule plus ends and orchestrates microtubule dynamics and directional cell migration. Sci Rep 2013;3:1681.
48. McDonald PC, Dedhar S. Carbonic anhydrase IX (CAIX) as a mediator of hypoxia-induced stress response in cancer cells. Sub-Cell Biochem 2014;75:255-69.
49. Cheng Z, Wang J, Su D, Pan H, Huang G, Li X, et al. Two novel mutations of the IRX4 gene in patients with congenital heart disease. Hum Genet 2011;130:657-62.
50. Nguyen HH, Takata R, Akamatsu S, Shigemizu D, Tsunoda T, Furihata M, et al. IRX4 at 5p15 suppresses prostate cancer growth through the interaction with vitamin D receptor, conferring prostate cancer susceptibility. Hum Mol Genet 2012;21:2076-85.
51. Tonachini L, Monticone M, Puri C, Tacchetti C, Pinton P, Rizzuto R, et al. Chondrocyte protein with a poly-proline region (CHPPR) is a novel mitochondrial protein and promotes mitochondrial fission. J Cell Physiol 2004;201:470-82.
52. Monticone M, Panfoli I, Ravera S, Puglisi R, Jiang MM, Morello R, et al. The nuclear genes Mtfr1 and Dufd1 regulate mitochondrial dynamic and cellular respiration. J Cell Physiol 2010;225:767-76.
53. Pejler G, Knight SD, Henningsson F, Wernersson S. Novel insights into the biological function of mast cell carboxypeptidase A. Trends Immunol 2009;30:401-8.
54. Gu X, Zheng M, Fei X, Yang Z, Li F, Ji C, et al. ZNF435, a novel human SCAN-containing zinc finger protein, inhibits AP-1-mediated transcriptional activation. Mol Cells 2007;23:316-22.
55. Bernard D, Martinez-Leal JF, Rizzo S, Martinez D, Hudson D, Visakorpi T, et al. CBX7 controls the growth of normal and tumor-derived prostate cells by repressing the Ink4a/Arf locus. Oncogene 2005;24:5543-51.
56. Scott CL, Gil J, Hernando E, Teruya-Feldstein J, Narita M, Martinez D, et al. Role of the chromobox protein CBX7 in lymphomagenesis. Proc Natl Acad Sci USA 2007;104:5389-94.